Antiviral treatment for treatment-naïve chronic hepatitis B: systematic review and network meta-analysis of randomized controlled trials

BACKGROUND: Chronic hepatitis B (CHB) infection poses a significant burden to public health worldwide. Most cases are clinically silent until late in the disease course. The main goal of current therapy is to improve survival and quality of life by preventing disease progression to cirrhosis and liv...

Descripción completa

Detalles Bibliográficos
Autores principales: Wong, William W. L., Pechivanoglou, Petros, Wong, Josephine, Bielecki, Joanna M., Haines, Alex, Erman, Aysegul, Saeed, Yasmin, Phoon, Arcturus, Tadrous, Mina, Younis, Mona, Rayad, Noha Z., Rac, Valeria, Janssen, Harry L. A., Krahn, Murray D.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6699129/
https://www.ncbi.nlm.nih.gov/pubmed/31426837
http://dx.doi.org/10.1186/s13643-019-1126-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6699129/
https://www.ncbi.nlm.nih.gov/pubmed/31426837
http://dx.doi.org/10.1186/s13643-019-1126-1

Ejemplares similares